P-849 The economic implications of adding granulocyte-colony stimulating factor (G-CSF) andlor antibiotics as secondary prophylaxis to small cell lung cancer (SCLC) patients at risk of febrile neutropenia (FN): A Markov model based on the clinical results of a prospective randomised phase III study
Timmer-Bonte, J., Termeer, E., Adang, E., Tjan-Heijnen, V.Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/S0169-5002(05)81342-X
Date:
July, 2005
File:
PDF, 144 KB
english, 2005